Products Documents
Technical Resources > Reading Room > TechNotes > Volume 11:4
TechNotes 11(4)  

RNA Amplification Just Got Better: MessageAmp™ II

• Compatible with GeneChip® analysis

• Amplify as little as 100 ng RNA in a single round

• Includes the new ArrayScript™ engineered M-MLV RT, engineered to maximize yields of full- length cDNA

• cRNA synthesis powered by MEGAscript®, the best in vitro transcription technology

• Consistently delivers high percent Present Calls and low 3'/5' ratios in GeneChip analysis

Gene arrays simultaneously measure the expression levels of thousands of genes in a single experiment and have become the most widely used method for assessing gene expression on a genome wide scale. The primary limitation of this technology is the requirement for large amounts of RNA for array hybridization. This is especially a problem when working with limited samples, such as small biopsies, mRNA-deficient cells and tissues, primary cell cultures, and laser capture microdissection (LCM) samples. This hurdle is usually overcome by using T7 RNA polymerase driven transcription of cDNA obtained from total RNA samples to generate sufficient amounts of amplified antisense or copy RNA (aRNA or cRNA). This amplification method is commonly referred to as the "Eberwine method" [1], "IVT method" or the "aRNA or cRNA method".

Ambion's new MessageAmp II aRNA Amplification Kit (patent pending) incorporates extensive improvements to the original MessageAmp aRNA Amplification Kit. Improving amplification involves more than simply increasing the final yield of labeled cRNA. Consistency with other amplification methods is also important so data can be compared across methods. Microarray expression profiling data from MessageAmp II and the Affymetrix recommended protocol for GeneChip™ analysis (see sidebar, Obtain Reproducible Microarray Data) show a high level of concordance. The new MessageAmp II Kit provides a wide dynamic range of RNA input (100 pg-5 µg), and a single round of amplification on samples as small as 100 ng generates sufficient cRNA for GeneChip analysis.

Improved Yields of Full-length cDNA
Even before developing MessageAmp II, it was apparent that the efficiencies of the reverse transcription step and the second strand cDNA synthesis reaction were critical for generating high yields of labeled cRNA with minimal change to the representation of message abundance in total RNA samples. This observation led to further optimization of the second strand cDNA synthesis reaction and the development of ArrayScript™, an M-MLV reverse transcriptase specifically engineered to generate high yields of full-length cDNA.

Higher Quality cDNA. Ambion's new ArrayScript produces higher yields of full-length cDNA compared to other reverse transcriptases (Figure 1). Figure 2 demonstrates that up to twice as much cRNA is synthesized when first-strand cDNA is generated with ArrayScript compared to wild type M-MLV, AMV, or other engineered M-MLV reverse transcriptases when low amounts of total RNA are used (~100 ng). This improved performance may eliminate the need for two rounds of cRNA amplification when working with small samples, thus reducing reagent cost and reaction time.

Second-strand cDNA Synthesis. The second-strand cDNA synthesis reaction has also been optimized specifically for the first-strand cDNA products generated with ArrayScript. This results in maximal conversion of first-strand cDNA into full-length double-stranded cDNA templates, thus increasing the average length of cRNA synthesized using MessageAmp II.

Figure 1. ArrayScript Reverse Transcriptase Synthesizes Intact cDNA Products as Long as 9 kb. cDNA synthesis was performed with 100 U of either ArrayScript RT, SuperScript™ II (SSII), SuperScript™ III (SSIII), or wild type (wt) M-MLV RT in a 20 µl reaction volume containing a synthetic, poly(A)-tailed 9 kb transcript (1 µg), 1X RT buffer, 0.5 µM oligo(dT) primer, 0.5 mM dNTPs, 40 U RNase Inhibitor, and 0.1 µl [α-32P]dATP. Reactions were incubated for 1 hr at 42ºC and quenched with EDTA. The cDNA products were resolved on a 1% denaturing agarose gel and detected with a phosphorimager.

 

Figure 2. ArrayScript™ Reverse Transcriptase Produces up to Twice the aRNA Yield in MessageAmp™ II. A comparison of ArrayScript RT (AS; 200 U), SuperScript II (SSII; 200 U); wild type M-MLV RT (200 U), and wild type AMV RT (10 U) in MessageAmp II conditions demonstrates that ArrayScript outperforms other commercial RTs. 90 ng HeLa-S3 total RNA (28S/18S ratio = 1.7) was heat denatured in the presence of T7 Oligo(dT) at 70°C for 10 minutes. Reverse transcription was initiated with the RT enzyme and incubated at 42ºC for 2 hr in an air incubator. Following first strand cDNA synthesis, DNA polymerase was added for second strand synthesis, which was incubated at 16ºC for 2 hr in a thermocycler (heated lid option turned off). The double-stranded cDNA was then filter purified and added to a 4 hr in vitro transcription reaction. Last, the resulting aRNA was purified by glass filter and eluted in nuclease-free water for analysis by Agilent 2100 bioanalyzer and NanoDrop® Spectrophotometer.

An Improved Amplification Kit
The RT and second-strand cDNA synthesis improvements, combined with the use of MEGAscript technology in the in vitro transcription reaction (IVT) result in the ability to use shortened IVT incubation times, and the generation of expression information from total RNA samples <1 µg. In two round amplification reactions, the MessageAmp II Kit facilitates robust amplification of total RNA from samples as low as 100 pg.

The MessageAmp II aRNA Amplification Kit contains all the necessary reagents for first-strand cDNA synthesis, RNase H digestion, second-strand synthesis, cDNA purification, in vitro transcription and aRNA purification. Reagents for 20 reactions and a detailed Instruction Manual are included.



back to sidebar

Figure 3. Replicate Analysis of Two Amplification Protocols. Normalized array results are plotted from replicate amplifications. Both MessageAmp™ II (top) and Affymetrix® standard protocol (bottom) were used to amplify with the identical total RNA samples (1 µg), and equivalent amounts of cRNA were hybridized on matched lot Human Genome Focus arrays. All IVT reactions were performed for 4 hours. Correlation values are included and indicate a measure of reproducibility with both methods.

back to top

Ordering Information for Ambion Products:

Cat# Product Name Size
AM1751 MessageAmp™ II aRNA Amplification Kit 20 rxns
For Research Use Only. Not for use in diagnostic procedures.
TechNotes Archive
Ordering Information

Related Links:
Array Analysis: The Basics
[read]


Master Mix Calculators for MessageAmp™-type Kits
[read]


Tips for Successful RNA Amplification
[read]


Obtain Reproducible Microarray Data

To evaluate the consistency of the MessageAmp™ II protocol, duplicate 1 µg samples of either human brain RNA, or HeLa S3 cell RNA (HeLa) were amplified using the MessageAmp II Kit. The cRNA produced was hybridized to Affymetrix® GeneChip® Human Genome Focus Arrays following the manufacturer's guidelines. As a reference, 1 µg of the same RNA samples were amplified using the Affymetrix GeneChip 3'-Amplification Reagents One-Cycle cDNA Synthesis Kit and IVT Labeling Reagents (from here on referred to as the Affymetrix protocol). Again, the resulting cRNA was hybridized to GeneChip Human Genome Focus Arrays following the manufacturer's guidelines. The Affymetrix quality assessment guidelines were met for all arrays in this study. This included 3'/5' ratios (under 2.0), percent Present Calls (50-53%), scaling factors, average background, as well as visual inspection of images. This assessment indicated that all array hybridizations were of high quality.

Signal values for each probe set were converted from .CEL files into a summary of expression values for each of the 8793 probe sets (genes). Expression
values were estimated using Robust Multi-array Average (RMA) [2-4] as implemented in BioConductor. The results are shown in Figure 3. We found that array results using MessageAmp II amplified RNA from both brain and HeLa cells were very reproducible, with correlation values of 0.998 and 0.997 respectively in this experiment. The Affymetrix protocol gave similar results; correlation values were 0.996 and 0.992 between the brain and HeLa replicates.

A number of other microarray experiments were conducted to compare the MessageAmp II Kit to the Affymetrix protocol on a variety of different criteria including correspondence of replicates, Present/Absent Call Concordance, the effect of IVT incubation times on microarray signal characteristics, and expression analysis at low RNA inputs. Furthermore, we have assessed the concordance of data generated with the new MessageAmp II Kit to that generated with the original MessageAmp Kit. [View data]

REFERENCES

1. Van Gelder RN, von Xastrow ME, Yool A, Dement DC, Barchas JD, Eberwine JH (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA87: 1663-7.

2. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-93.

3. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix GeneChip probe level data. Nucl Acids Res 31(4):e15.

4. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-64.

 
Home | Products | Technical Resources | What's New | About Us | Contact Us
Advanced Search | Site Map | Privacy | Trademarks/Legal | Web Feedback | Jobs
© Applied Biosystems. All rights reserved.